Skip to main content

Advertisement

SpringerLink
Log in

CYP2B6, ABCB1 and OPRM1 profile in a stillborn affected by chronic methadone intoxication

  • Letter to the Editor
  • Published:
Forensic Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kalin JR (2014) Incidence of fetal drug exposure in Alabama: 2004–2011. J Forensic Sci 59:1029–1035

    Article  CAS  PubMed  Google Scholar 

  2. Montanari E, Bonasoni MP, Licata M, Salomone A, Gerace E, Vivarelli M, Giorgetti R, Tagliabracci A (2018) Toxicological and histological analyses for a stillborn delivered by a mother under methadone maintenance therapy. Forensic Toxicol 36:514–524

    Article  CAS  Google Scholar 

  3. Newman RG, Bashkow S, Calko D (1975) Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program. Am J Obstet Gynecol 121:233–237

    Article  CAS  PubMed  Google Scholar 

  4. Archie CL, Lee MI, Sokol RJ, Norman G (1989) The effects of methadone treatment on the reactivity of the nonstress test. Obstet Gynecol 74:254–255

    CAS  PubMed  Google Scholar 

  5. Crettol S, Déglon J-J, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, Monnat M, Hüttemann H, Baumann P, Eap CB (2005) Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther 78:593–604

    Article  CAS  PubMed  Google Scholar 

  6. Dobrinas M, Crettol S, Oneda B, Lahyani R, Rotger M, Choong E, Lubomirov R, Csajka C, Eap CB (2013) Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study. Pharmacogenet Genomics 23:84–93

    Article  CAS  PubMed  Google Scholar 

  7. Fonseca F, de la Torre R, Diaz L, Pastor A, Cuyas E, Pizarro N, Khymenets O, Farre M, Torrens M (2011) Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response. PLoS One 6:e19527. https://doi.org/10.1371/journal.pone.0019537 (open access article)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gadel S, Crafford A, Regina K, Kharasch ED (2013) Methadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6. Drug Metab Dispos 41:709–713

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hung CC, Chiou MH, Huang BH, Hsieh YW, Hsieh TJ, Huang CL, Lane HY (2011) Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Pharmacogenomics 12:1525–1533

    Article  CAS  PubMed  Google Scholar 

  10. Kharasch ED, Regina KJ, Blood J, Friedel C (2015) Methadone pharmacogenetics: CYP2B6 polymorphisms determine plasma concentrations, clearance, and metabolism. Anesthesiology 123:1142–1153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kharasch ED, Stubbert K (2013) Role of cytochrome P4502B6 in methadone metabolism and clearance. J Clin Pharmacol 53:305–313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kringen MK, Chalabianloo F, Bernard J-P, Bramness J, Molden E, Høiseth G (2017) Combined effect of CYP2B6 genotype and other candidate genes on a steady-state serum concentration of methadone in opioid maintenance treatment. Ther Drug Monit 39:550–555

    Article  CAS  PubMed  Google Scholar 

  13. Lee H-Y, Li J-H, Sheu Y-L, Tang H-P, Chang W-C, Tang T-C, Yeh Y-C, Wang S-Y, Liu R-H (2013) Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan. Biomed Res Int 2013:741403. https://doi.org/10.1155/2013/741403 (open access article)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ (2013) CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Addict Biol 18:709–716

    Article  CAS  PubMed  Google Scholar 

  15. Wang S-C, Ho I-K, Tsou H-H, Tian J-N, Hsiao C-F, Chen C-H, Tan H, Lin L, Wu C-S, Su L-W, Huang C-L, Yang Y-H, Liu M-L, Lin K-M, Chen C-Y, Liu S, Wu H-Y, Chan H-W, Tsai M-H, Lin P-S, Liu Y-L (2011) CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. J Clin Psychopharmacol 31:463–469

    Article  CAS  PubMed  Google Scholar 

  16. Ahmad T, Valentovic MA, Rankin GO (2018) Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics. Biochem Pharmacol 153:196–204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bunten H, Liang WJ, Pounder DJ, Seneviratne C, Osselton D (2010) OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clin Pharmacol Ther 88:383–389

    Article  CAS  PubMed  Google Scholar 

  18. Bunten H, Liang WJ, Pounder DJ, Seneviratne C, Osselton D (2011) Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations. J Anal Toxicol 35:431–437

    Article  CAS  PubMed  Google Scholar 

  19. Christoffersen DJ, Damkier P, Feddersen S, Moller S, Thomsen JL, Brasch-Andersen C, Brøsen K (2016) The ABCB1, rs9282564, AG and TT genotypes and the COMT, rs4680, AA genotype are less frequent in deceased patients with opioid addiction than in living patients with opioid addiction. Basic Clin Pharmacol Toxicol 119:381–388

    Article  CAS  PubMed  Google Scholar 

  20. Madadi P, Kelly LE, Ross CJ, Kepron C, Edwards JN, Koren G (2016) Forensic investigation of methadone concentrations in deceased breastfed infants. J Forensic Sci 61:576–580

    Article  CAS  PubMed  Google Scholar 

  21. Walter C, Lötsch J (2009) Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 146:270–275

    Article  CAS  PubMed  Google Scholar 

  22. Haerian BS, Haerian MS (2013) OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics 14:813–824

    Article  CAS  PubMed  Google Scholar 

  23. Oertel BG, Kettner M, Scholich K, Renné C, Roskam B, Geisslinger G, Schmidt PH, Lötsch J (2009) A common human µ-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem 284:6530–6535

    Article  CAS  PubMed  Google Scholar 

  24. Barratt DT, Coller JK, Hallinan R, Byrne A, White JM, Foster DJR, Somogyi AA (2012) ABCB1 haplotype and OPRM1 118A>G genotype interaction in methadone maintenance treatment pharmacogenetics. Pharmgenomics Pers Med 5:53–62. https://doi.org/10.2147/PGPM.S29272 (open access article)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Maurer HH (1999) Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. J Chromatogr B 733:3–25

    Article  CAS  Google Scholar 

  26. Li Y, Kantelip J-P, Gerritsen-van Schieveen P, Davani S (2008) Interindividual variability of methadone response: impact of genetic polymorphism. Mol Diagn Ther 12:109–124

    Article  CAS  PubMed  Google Scholar 

  27. Ahmad T, Sabet S, Primerano DA, Richards-Waugh LL, Rankin GO (2017) Tell-tale SNPs: the role of CYP2B6 in methadone fatalities. J Anal Toxicol 41:325–333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Crettol S, Deglon J-J, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, Monnat M, Eap CB (2006) ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clin Pharmacol Ther 80:668–681

    Article  CAS  PubMed  Google Scholar 

  29. Levran O, O’Hara K, Peles E, Li D, Barral S, Ray B, Borg L, Ott J, Adelson M, Kreek MJ (2008) ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet 17:2219–2227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R (2016) Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT). Am J Drug Alcohol Abuse 42:587–596

    Article  PubMed  Google Scholar 

  31. Kong X, Deng H, Alston T, Kong Y, Wang J (2017) Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence. Oncotarget 8:84329–84337. https://doi.org/10.18632/oncotarget.20939 (open access article)

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kong X, Deng H, Gong S, Alston T, Kong Y, Wang J (2017) Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies. BMC Med Genet 18:120. https://doi.org/10.1186/a12881-017-0478-4 (open access article)

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H, Damadzic R, Eskay R, Schoor M, Thorsell A, Schwandt ML, Sommer WH, George DT, Parsons LH, Herscovitch P, Hommer D, Heilig M (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16:809–817

    Article  CAS  PubMed  Google Scholar 

  34. Manini AF, Jacobs MM, Vlahov D, Hurd YL (2013) Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. J Med Toxicol 9:148–154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Wang L, Wei C, Xiao F, Chang X, Zhang Y (2019) Influences of COMT rs4680 and OPRM1 rs1799971 polymorphisms on chronic postsurgical pain, acute pain, and analgesic consumption after elective cesarean delivery. Clin J Pain 35:31–36

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Polytechnic University of Marche, Via Conca 71, Ancona, 60030, Italy

    Eva Montanari, Federica Alessandrini, Francesco Paolo Busardò, Raffaele Giorgetti & Adriano Tagliabracci

  2. Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, V.le Risorgimento 80, Reggio Emilia, 42123, Italy

    Maria Paola Bonasoni

  3. Laboratory of Translational Research, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, V.le Risorgimento 80, Reggio Emilia, 42123, Italy

    Raffaele Frazzi

  4. Hepatopancreatobiliary and Transplantation Surgery Unit, Experimental and Clinical Medicine Department, Polytechnic University of Marche, Via Conca 71, Ancona, 60030, Italy

    Federico Mocchegiani

Authors
  1. Eva Montanari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Paola Bonasoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federica Alessandrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raffaele Frazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Federico Mocchegiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Paolo Busardò
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raffaele Giorgetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Adriano Tagliabracci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eva Montanari.

Ethics declarations

Conflict of interest

The authors have no financial or other relations that could lead to a conflict of interest.

Ethical approval

In Italy, there is no legislation that forbids the use of human tissues collected during an autopsy, provided that the samples are made anonymous and linked exclusively to codes. We followed this privacy-guaranteed principle. The mother was not traceable, and it was not possible to obtain her consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Montanari, E., Bonasoni, M.P., Alessandrini, F. et al. CYP2B6, ABCB1 and OPRM1 profile in a stillborn affected by chronic methadone intoxication. Forensic Toxicol 37, 507–516 (2019). https://doi.org/10.1007/s11419-019-00478-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11419-019-00478-x

Search

Navigation